Published January 23, 2023 | Version v1
Journal article Open

Production of rare cycloartane saponins from Astragalus thracicus (Griseb) compared to Astragalus membranaceus (Fisch.) Bunge – native and biotechnological sources

  • 1. Medical University of Sofia, Sofia, Bulgaria
  • 2. Centre of Pharma Research, Institute of Pharmaceutical Biology, Munich, Germany

Description

The aim of this study is a comparative metabolomic analysis between the endangered species Astragalus membranaceus and endemic species Astragalus thracicus concerning cycloartane saponins. In addition, in vitro shoots, callus, and suspension cultures of A. thracicus were successfully established to conserve the biodiversity of those endemic species and to increase the amount of produced saponins. The comparison was made according to the quantity of cycloartane saponins astragaloside I (1), astragaloside II (2), and astragaloside IV (4) to the reference standards for the same compounds by UHPLC-HRESI-MS analysis. The in vitro root cultures of A. thracicus reached two folds higher amounts of saponins (1.50 mg/g DW (1), 1.01 mg/g DW (2), and 0.91 mg/g DW (3)) than the native root of A. thracicus (1.14 mg/g DW (1) 0.47 mg/g DW (2), 0.40 mg/g DW (3)), and up to six times higher when compared with roots A. membranaceus (0.23 mg/g DW (1), 0.18 mg/g DW (2) and 0.05 mg/g DW (3)).

Files

PHAR_article_97782.pdf

Files (555.7 kB)

Name Size Download all
md5:98ae9b07019655807833177aacfe7f0b
499.4 kB Preview Download
md5:925e1c2a139dbc2fb3cbc014c3829e36
56.4 kB Preview Download

Additional details